HLA
TXG icon

Hamilton Lane Advisors’s 10x Genomics TXG Stock Holding History

Hamilton Lane Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,718
Closed -$600K – 26
2023
Q4 		$600K Buy
+10,718
New +$466K 0.25% 22
2023
Q3 		– Sell
-18,731
Closed -$1.05M – 48
2023
Q2 		$1.05M Buy
18,731
+10,988
+142% +$595K 0.46% 32
2023
Q1 		$432K Sell
7,743
-18,667
-71% -$872K 0.14% 45
2022
Q4 		$962K Buy
26,410
+18,667
+241% +$610K 0.35% 32
2022
Q3 		$221K Hold
7,743
– – 0.08% 57
2022
Q2 		$350K Hold
7,743
– – 0.14% 53
2022
Q1 		$589K Hold
7,743
– – 0.13% 51
2021
Q4 		$1.15M Hold
7,743
– – 0.15% 52
2021
Q3 		$1.13M Sell
7,743
-14,521
-65% -$2.49M 0.19% 50
2021
Q2 		$4.36M Buy
22,264
+1,313
+6% +$238K 1.36% 18
2021
Q1 		$3.79M Sell
20,951
-54,580
-72% -$9.43M 1.24% 19
2020
Q4 		$10.7M Buy
75,531
+38,444
+104% +$5.58M 3.99% 6
2020
Q3 		$4.62M Buy
37,087
+32,290
+673% +$3.39M 2.24% 8
2020
Q2 		$428K Buy
+4,797
New +$374K 0.23% 32

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Hamilton Lane Advisors's TXG Position: Q1 2024 in Review

Hamilton Lane Advisors sold out of 10x Genomics (TXG) in Q1 2024, closing a stake of 10,718 shares — an estimated $600K sold.

Hamilton Lane Advisors first reported a position in TXG in Q2 2020 and held it in 14 quarters. The position peaked at $10.7M in Q4 2020. 290 funds tracked by Wall St. Rank hold TXG as of Q1 2024.

  • Hamilton Lane Advisors reported no remaining 10x Genomics position as of Q1 2024 after selling out during the quarter.
  • Hamilton Lane Advisors sold 10,718 10x Genomics shares in Q1 2024, an estimated $600K.
  • Hamilton Lane Advisors first reported a position in 10x Genomics in Q2 2020 and held it in 14 quarters.
  • Hamilton Lane Advisors's 10x Genomics position peaked at $10.7M in Q4 2020.
  • 290 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2024.

Based on Hamilton Lane Advisors's 13F filing for Q1 2024, filed 1 May 2024.